跳至主要内容
临床试验/NCT01860378
NCT01860378已完成早期 1 期

Retail Pharmacy Vouchers to Promote Tdap Vaccination for Adults Living With Infants

Children's Hospital of Philadelphia2 个研究点 分布在 1 个国家目标入组 149 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
149
试验地点
2
主要终点
Rate of Tdap Vaccination

研究概览

简要总结

This study is a small-scale randomized, placebo-controlled factorial trial of two interventions to increase Tetanus, diphtheria and acellular pertussis (Tdap) immunization rates among infant caregivers. Specifically, the trial will compare a full cost vs. $5 Tdap voucher with or without an educational video.

详细描述

The incidence of pertussis, a highly contagious respiratory illness, has more than tripled in the past five years, and is on track this year to be the most severe in over a half century. Pertussis is particularly dangerous, and commonly fatal, for young infants who have not completed the primary vaccination series. To protect infants, pregnant women and adult caregivers should receive Tdap vaccination, but coverage is estimated at only 10% for adult caregivers in close contact with infants.

The objective of this study is to conduct a small-scale randomized controlled trial of an intervention to increase Tdap immunization rates among infant caregivers. The intervention is delivered at the newborn primary care visit and consists of two components: (1) Tdap vaccine vouchers redeemable at neighborhood retail pharmacies and (2) video-based education. The vouchers improve vaccine supply by reducing cost and improving accessibility of the vaccine, while the education component increases demand for the vaccine by making salient the dangers of pertussis and the importance adult vaccination to "cocoon" vulnerable infants. We will evaluate the feasibility and acceptability of each component or both compared to none and assess the impact on the vaccination of parents/caregivers of newborn infants.

Recruitment for this pilot study will take place at a pediatric primary care practice site affiliated with a large children's hospital in Philadelphia, Pennsylvania (PA). The practice schedules approximately 135 newborn visits per month, typically at 2-14 days of life. Participants will redeem Tdap vaccine vouchers at 2 local Rite Aid pharmacies which are the closest Rite Aid locations to the clinic site. The pharmacy accepts all major insurance plans, although most plans (including Medicaid) do not cover Tdap vaccine delivered in pharmacies.

All caregivers ≥ 18 years old who accompany an infant to a newborn visit will be approached by the study coordinator and details of the study will be explained. Caregivers will be asked to participate in the study and if interested, informed consent will be obtained before any study related procedures are performed. Potential subjects will then be screened using the protocol inclusion and exclusion criteria. The research assistant will utilize a data collection form to collect demographic data. After completion of the data collection form, participants will view an educational video if randomized to the education arm. After viewing the educational video, or after completion of data collection form for those who were not randomized to video, participants will receive an envelope containing the Tdap and baby care item voucher or gift card.

Unvaccinated caregivers will receive an envelope containing 2 vouchers or a voucher and a gift card. The vouchers are: one for Tdap vaccination and one for a baby care item. Vouchers will be redeemable only at the two participating nearby Rite Aid pharmacies, will have no monetary value, and cannot be redeemed for any items other than the specified vaccine/baby care product.The gift card can be redeemed at any Rite Aid pharmacy.All envelopes will also contain the Center for Disease Control and Prevention (CDC) Vaccine Information Sheet (V.I.S) for the Tdap vaccine. Participants will be randomized to receive either: (1) a voucher for the full price of a Tdap vaccine ($63.99) + a baby care product voucher/or gift card, or (2) a voucher for $5 off a Tdap vaccine + a baby care product voucher/or gift card. The baby care product voucher / gift card will allow us to assess the proportion of respondents who make a trip to one of the pharmacies following the primary care visit and may also increase the probability that the study participants will visit one of the designated retail pharmacies. The full cost voucher removes any cost barriers related to the Tdap vaccine. The $5 voucher allows us to assess the effect of increased awareness, convenience, and accessibility on vaccine uptake, but without a significant price change. If two unvaccinated caregivers accompany an infant and both choose to enroll in the study, they may receive discordant Tdap voucher amounts; however, both will receive baby care product vouchers / gift cards.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All caregivers who report that they have never received Tdap
  • Mothers who did not receive Tdap during their most recent pregnancy or since the birth of the child, even if she received Tdap during a previous pregnancy, as Tdap is now recommended for all pregnant women during each pregnancy.
  • Previous receipt of a tetanus containing vaccine (i.e. Td or TT), regardless of the time interval since receipt of the tetanus-containing vaccine will be also eligible for the study.
  • If a participant is certain they have not received Tdap within the past year but uncertain whether he/she has ever received Tdap, we will offer enrollment and encourage participants to obtain immunization records to confirm their status before voucher redemption. Rite Aid will follow their screening procedures which also includes assessing immunization status. Participants who do not know their Tdap vaccination status will receive the voucher intervention.

排除标准

  • Any adult caregiver who has previously received Tdap
  • For recently-pregnant women: If a mother who received Tdap during her most recent pregnancy (2nd trimester or 3rd trimester) or since the birth of the child. Also, if the mother is unsure of her vaccination status and possibly received the vaccine during this pregnancy or in the last year

结局指标

主要结局

Rate of Tdap Vaccination

时间窗: 5 months

The primary outcome of interest is the difference in vaccination rates between those who received the vouchers vs. those who did not and between those who received the educational video vs. those who did not. We are also interested in measuring whether the educational video acts as an effect modifier in the association between receipt of the voucher and vaccination rates.

次要结局

  • Proportion of all vouchers that are redeemed(5 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

尚未招募
不适用
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in PregnancyNon-birthing Partner Vaccination in PregnancyTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationVaccine Exposure During Pregnancy
NCT06135636Women and Infants Hospital of Rhode Island150
已完成
2 期
Traveler's Diarrhea (TD) Vaccine Asia Efficacy StudyTraveler's Diarrhea
NCT01040325Intercell USA, Inc.723
终止
2 期
A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and OlderRespiratory Syncytial VirusesRespiratory Tract Diseases
NCT03982199Janssen Vaccines & Prevention B.V.5,815
已完成
2 期
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Hodgkin LymphomaAdult Non-Hodgkin LymphomaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveCytomegaloviral InfectionHematopoietic and Lymphoid Cell NeoplasmHLA-A*0201 Positive Cells PresentAdult Lymphoblastic LymphomaMyeloproliferative NeoplasmChronic Lymphocytic LeukemiaMyelodysplastic SyndromeMyelofibrosis
NCT02396134City of Hope Medical Center61
已完成
不适用
Low Cost Interventions to Improve Adherence to Childhood Immunization ScheduleChildhood Immunization CompletionChildhood Immunization DropoutImmunization CardCenter Based Education
NCT00602056University of Alabama at Birmingham1,506